Neoadjuvant nivolumab for patients with non-metastatic high risk kidney cancer
A recent phase 1 trial showed that treatment with nivolumab [...]
Surgery after targeted therapy or immunotherapy for metastatic kidney cancer
A recent retrospective study (looking back at the patients’ cases [...]
Nephrectomy after complete response to immunotherapy
A retrospective study looked at the clinical and surgical outcomes [...]
ESMO 2019: ADAPTeR study to evaluate the role of nivolumab before and after surgery – results of biomarker analysis
Results from the ADAPTeR study to evaluate the role of [...]
ESMO 2019: Avelumab plus axitinib in patients who had not had nephrectomy
Results from a post-hoc analysis of JAVELIN-Renal 101 in patients [...]
Neoadjuvant axitinib to allow partial nephrectomy of cT2a renal tumours
A phase 2 study published in the British Journal of [...]
Kidney cancer experts talk about the latest advances in treatments
The following interviews with kidney cancer experts discuss the latest [...]
EAU 2019
The European Association of Urology (EAU) held its annual congress [...]
Neoadjuvant axitinib shrinks kidney tumours to allow for partial nephrectomy
A recent phase II study of 18 patients with clear-cell renal [...]
Adjuvant therapy for renal cell carcinoma
The following articles from various urology conferences in 2018 summarise [...]
